Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188041 · ClinicalTrials.gov registry record · NA
Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
A NA study, sponsored by Kent Hospital, Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT04188041: Completed NA study, sponsored by Kent Hospital, Rhode Island.
NCT04188041 is a NA study that has completed, run by Kent Hospital, Rhode Island. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04188041, a NA study, has completed, sponsored by Kent Hospital, Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study explores primary care team members' knowledge, attitudinal, and skill gaps related to latent tuberculosis infection (LTBI) testing and treatment. The gaps identified will inform the design of a survey and telementoring educational program (tuberculosis (TB) infection ECHO course). The EMR data query will further explore the reach of the expansion for community healthcare outcomes (ECHO) model. The hypothesis for this study is that the TB infection ECHO course will be feasible, will have a significant impact on primary care provider participants' learning and performance related to LTBI testing and treatment in their primary care practices, and will increase the number of LTBI tests and treatment prescribed in primary care.
Primary Outcome
Number of consented participants attending each expansion for community healthcare outcomes (ECHO) session who consented to participate in the course
Interventions
- OTHER TB Infection ECHO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-10-02 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT04188041 record still lists
NCT04188041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which TB Infection ECHO is the first listed.
NCT04188041 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04188041 about?
NCT04188041 is a clinical study titled "Improving Rhode Island's Tuberculosis Preventive Services in Primary Care". This study explores primary care team members' knowledge, attitudinal, and skill gaps related to latent tuberculosis infection (LTBI) testing and treatment. The gaps identified will inform the design of a survey and telementoring educational program (tuberculosis (TB) infection ECHO course). The EMR...
What is the current status of trial NCT04188041?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-10-02. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT04188041?
The interventions under investigation include: TB Infection ECHO (OTHER).
Who is sponsoring clinical trial NCT04188041?
This trial is sponsored by Kent Hospital, Rhode Island, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04188041's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI